Project AAMBI2 – Asphyxia Associated Metabolite BiomarkerInvestigation 2

Basic data

Acronym:
AAMBI2
Title:
Asphyxia Associated Metabolite BiomarkerInvestigation 2
Duration:
29/01/2019 to 31/08/2020
Abstract / short description:
Within the AAMBI 2-study the predictive power of AAMBI-study will be confirmed (or the selection of biomarkers may be adapted) according to refined outcome group allocation based on neonatal and newly generated two year neurocognitive outcome data.
Keywords:
biomarker
Biomarker
neonatology
Neonatologie
Neuropädiatrie

Involved staff

Managers

University Children’s Hospital - Department of Paediatrics
Hospitals and clinical institutes, Faculty of Medicine
Faculty of Medicine
University of Tübingen

Local organizational units

University Children’s Hospital - Department of Paediatrics
Hospitals and clinical institutes
Faculty of Medicine

Funders

Köln, Nordrhein-Westfalen, Germany
Help

will be deleted permanently. This cannot be undone.